Cargando…
A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma
BACKGROUND: The immune non-recognition is often the underlying cause of failure in tumor immunotherapeutic. This is because most tumor-related antigens are poorly immunogenic, and fail to arouse an efficient immune response against cancers. Here we synthesized a novel TLR7 agonist, and developed a s...
Autores principales: | Lin, Guimiao, Wang, Xiaomei, Yi, Wanxian, Zhang, Chuanxia, Xu, Gaixia, Zhu, Xiaomei, Cai, Zhiming, Liu, Yu, Diao, Yuwen, Lin, Marie Chia-Mi, Jin, Guangyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455914/ https://www.ncbi.nlm.nih.gov/pubmed/25990580 http://dx.doi.org/10.1186/s12967-015-0524-y |
Ejemplares similares
-
Cardiotoxicity of Intravenously Administered CdSe/ZnS Quantum Dots in BALB/c Mice
por: Li, Li, et al.
Publicado: (2019) -
Synthetic MUC1 breast cancer vaccine containing a Toll-like receptor 7 agonist exerts antitumor effects
por: Liu, Yu, et al.
Publicado: (2020) -
Cytotoxicity of InP/ZnS Quantum Dots With Different Surface Functional Groups Toward Two Lung-Derived Cell Lines
por: Chen, Ting, et al.
Publicado: (2018) -
The Codelivery of siRNA and QDs by pH-Responsive Micelle for Hepatoma Cancer Cells
por: Cao, Zhonglin, et al.
Publicado: (2019) -
An octamer of enolase from Streptococcus suis
por: Lu, Qiong, et al.
Publicado: (2012)